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H I G H L I G H T S
• We evaluated cholesterol metabolism in 0–15 year-old children without dyslipidemia.
• Serum non-cholesterol sterols depicted cholesterol synthesis and absorption.
• From the age of 1 year, cholesterol homeostasis was intact.
• From the age of 1–10 years cholesterol absorption prevailed cholesterol synthesis.
• This new finding emphasizes the importance of healthy diet from early childhood.








A B S T R A C T
Background and aims: The profile of cholesterol metabolism, i.e., high absorption vs. high synthesis, may have a
role in the development of atherosclerosis, the early lesions of which can be present already in childhood. Since
there is no information on cholesterol metabolism in children from birth to adolescence, we evaluated choles-
terol metabolism in 0–15 year-old children and adolescents without dyslipidemia.
Methods: The study population consisted of 96 children (39 girls, 57 boys) divided into age groups<1 (n=14),
1–5 (n=37), 6–10 (n=24), and 11–15 (n= 21) years. Cholesterol metabolism was assessed by analysing
serum non-cholesterol sterols, biomarkers of cholesterol synthesis and absorption, with gas-liquid chromato-
graphy.
Results: Serum non-cholesterol sterol ratios to cholesterol did not differ between gender. Cholesterol precursors
squalene, cholestenol, and desmosterol were higher in the<1 year than in the older age groups, whereas la-
thosterol was highest in the 11–15 year old. Plant sterols were low in the age group< 1 year, after which they
did not differ between the groups. Cholestanol was not age-dependent. From the age of 1 year, cholesterol
homeostasis was intact. Cholesterol absorption prevailed cholesterol synthesis from 1 to 10 years of age (e.g.,
lathosterol/cholestanol ratio 0.35 ± 0.03 and 0.45 ± 0.05 in 1–5 and 6–10 vs. 0.66 ± 0.08 in 11–15 year-old
(mean ± SE, p < 0.001).
Conclusions: Serum non-cholesterol sterols had different individual profiles by age in childhood and adolescence.
From 1 to 10 years of age, cholesterol absorption prevailed cholesterol synthesis. This novel finding emphasizes
the importance of dietary aspects related to cardiovascular risk even from early childhood.
1. Introduction
Cholesterol is an essential lipid for the development, growth, and
wellbeing of humans. In newborn children, cord blood cholesterol
concentration is 1.5 mmol/l, on average [1–4]. During the first year of
life, cholesterol concentration in serum increases to about 4–5mmol/l
[5], a level that remains throughout the childhood [6]. Serum choles-
terol concentration, as well as cholesterol metabolism, is regulated by
genetic, dietary, hormonal, and lifestyle factors, e.g., in newborns with
heterozygous familial hypercholesterolemia, the concentration of cord
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blood cholesterol is elevated up to about 2.4mmol/l, and at the age of 1
year, serum cholesterol concentration is about 8mmol/l [2]. Already in
childhood and adolescence, elevated serum and LDL cholesterol con-
centration can lead to atherosclerotic changes in arterial wall [7]. In
addition to LDL cholesterol, the whole-body cholesterol metabolism
may have a role in the development of atherosclerosis. This was sug-
gested in adult cohorts in which high cholesterol absorption efficiency
increased the risk of coronary events regardless of LDL cholesterol
concentration [8–11]. The growth and development in childhood and
adolescence question the whole-body cholesterol metabolism, which
may vary between different ages. To our knowledge, there is only a
limited number of studies on limited age periods dealing with choles-
terol metabolism in healthy children and adolescents [1–4,12–14], and
there are no studies reaching all age groups from newborn to adoles-
cence. Thus, there is no information on whether the metabolic profile of
cholesterol differs between age groups or gender in children and ado-
lescents. Therefore, the aim of this study was to evaluate cholesterol
metabolism in healthy children from 0 to 15 years of age by analysing
serum non-cholesterol sterols, which in general are used as biomarkers
of cholesterol synthesis and cholesterol absorption [15–19].
2. Patients and methods
2.1. Study population
The study population consisted of consecutive 0-15 year-old day-
surgery patients of our hospital during the years 2009–2015, who were
otherwise healthy and did not have dyslipidemia, diabetes, thyroid,
renal, hepatobiliary, gastrointestinal, or malignant disease. Written
informed consent was received from all patients or their caregivers
before any procedure. The study was performed according to the
principles of the Declaration of Helsinki. The Ethics Committee of the
Helsinki University Central Hospital had approved the study protocol.
2.2. Study design
Fasting blood samples were drawn after a 12-h fast in the morning
before the surgery. The subjects of the study population were weighed
and height was measured, and medical history and possible drug
treatment were recorded from the medical records. All subjects had
been on their habitual home diet, but more detailed dietary information
or the breastfeeding status was not recorded.
2.3. Methods
Serum cholesterol and non-cholesterol sterols and squalene were
quantified by capillary gas-liquid chromatography (GLC) with flame
ionization detection and using a 50-m capillary column (Ultra 2,
Agilent Technologies, Wilmington, DE) with 5α-cholestane as the in-
ternal standard [20]. The following non-cholesterol sterols were ana-
lysed: squalene, cholestenol (5α-cholest-8-en-3β-ol), desmosterol, and
lathosterol (cholesterol precursors), cholestanol (a metabolite of cho-
lesterol), and campesterol, sitosterol, stigmasterol, and avenasterol
(plant sterols). To eliminate the effects of variation of non-cholesterol
sterol transporters (mainly LDL) on the serum sterol concentrations, the
non-cholesterol sterol concentrations were standardized and divided by
the cholesterol concentration of the same GLC run and expressed as
ratios to cholesterol (102 x μmol/mmol of cholesterol). In general, the
ratios to cholesterol of the serum cholesterol precursors reflect choles-
terol synthesis, while those of plant sterols (campesterol, sitosterol, and
avenasterol) and cholestanol reflect cholesterol absorption efficiency.
We also calculated the synthesis marker/absorption marker ratios
cholestenol/cholestanol and lathosterol/cholestanol, which reflect
cholesterol metabolism, the lathosterol/desmosterol ratio reflecting the
activity of the two pathways of cholesterol synthesis, and the campes-
terol/cholestanol ratio, a biomarker of dietary phytosterol intake [21].
2.4. Statistics
Statistical analyses were performed with SPSS for Windows 22.0
(SPSS, Chicago, IL). The normality and homogeneity of variance as-
sumptions were checked before further analyses. Comparison of con-
tinuous variables between groups were performed by analysis of var-
iance followed by independent samples t-test or Mann-Whitney test if
the normality and homogeneity of variance were not reached after
logarithmic transformation. Non-continuous variables were tested with
Chi-square or Fisher's exact test. Spearman correlation coefficients were
calculated. To control the overall level, Bonferroni adjustment was
used. A p-value of< 0.05 was considered statistically significant. The
results are expressed as mean ± SE.
3. Results
The study population consisted of 96 children and adolescents.
Thirty-nine subjects were girls and 57 were boys (Table 1). The mean
age of the study population was 6.6 ± 0.5 (SE) years ranging from 0.10
to 15.94 years, and there was no difference between girls and boys.
Table 1
Gender, age, weight, serum cholesterol concentration and serum non-cholesterol sterol ratios to cholesterol in the study population divided in different age groups.
Variables Age < 1 year n= 14 Age 1–5 years n= 37 Age 6–10 years n= 24 Age 11–15 years n= 21 p
Girls/boys, n 3/11 17/20 11/13 8/13 0.670
Age, years 0.36 ± 0.06 3.82 ± 0.22 8.27 ± 0.29 13.62 ± 0.34 <0.001
Weight, kg 7.6 ± 1.2 16.5 ± 0.6 29.7 ± 1.6 51.1 ± 2.9 <0.001
Cholesterol, mmol/l 3.38 ± 0.20 3.75 ± 0.1 4.14 ± 0.14b 3.94 ± 0.14 0.008
Squalenea 21.6 ± 1.9 13.0 ± 0.9b 12.7 ± 0.7b 16.3 ± 1.7 <0.001
Cholestenola 20.7 ± 1.6 11.3 ± 0.7b 12.7 ± 1.0b 15.9 ± 1.3b <0.001
Desmosterola 158.5 ± 13.6 77.7 ± 2.1b 79.7 ± 2.4b 91.5 ± 3.1b <0.001
Lathosterola 66.3 ± 5.7 60.1 ± 3.5 77.2 ± 6.4 100.9 ± 8.6c <0.001
Campesterola 154.4 ± 35.3 344.9 ± 18.9b 361.6 ± 19.0b 313.3 ± 23.1b <0.001
Sitosterola 140.2 ± 40.4 197.8 ± 8.9 204.1 ± 11.8 174.2 ± 14.1 0.068
Stigmasterola 19.0 ± 2.3 28.7 ± 1.4b 30.8 ± 3.0b 26.1 ± 1.4 0.006
Avenasterola 24.3 ± 4.1 53.0 ± 2.7b 52.8 ± 3.0b 46.1 ± 3.0b <0.001
Cholestanola 170.1 ± 8.3 176.3 ± 5.0 180.5 ± 8.6 168.3 ± 7.2 0.628
Mean ± SE.
a 102 μmol/mmol cholesterol.
b Significantly different from age< 1 year.
c Significantly different from all other age groups.
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Weight was available from 34 girls and 55 boys, but height was mea-
sured only in 6 girls and 21 boys, so that body mass index was not
calculated. Weight ranged from 6.2 kg to 64.0 kg in girls and from 4.4
to 76.7 kg in boys, respectively. The mean serum cholesterol con-
centration was 3.83 ± 0.07mmol/l in the whole study population
ranging from 2.52 to 5.01mmol/l in the girls and from 2.21 to
5.47mmol/l in the boys, with no difference between the genders. The
main reasons for the day-surgery were: corrections of umbilical or in-
guinal hernia or testis retention, removal of nevus or other skin, sub-
cutaneous, cartilage, or bone lesions, all benign in histology, arthro-
scopy, different endoscopies, or circumcision.
The study population was divided into 5-year age groups 1–5
(n=37), 6–10 (n=24), and 11–15 years (n= 21) (Table 1). Less than
1-year old (n= 14) subjects were left as their own group because some
of the serum non-cholesterol sterols behaved differently in the first year
of life compared with the other age groups. According to power analysis
based on previous data [2], with an α level of 0.05 (two-sided) and
statistical power of 0.80, the required minimal study population per age
group should be 12, so that each group fulfilled the criteria of optimal
size. In the age group 1–5 years, the boys were heavier than the girls
(17.9 ± 0.8 kg vs. 14.5 ± 0.7 kg, p=0.008), but in the other age
groups there was no gender difference in weight. Serum cholesterol
concentration was higher in the girls than in the boys in the age
group<1 year (4.14 ± 0.28 vs. 3.18 ± 0.19mmol/l, p=0.047), but
in the other age groups neither serum cholesterol nor non-cholesterol
sterols differed between the genders.
3.1. Serum cholesterol and non-cholesterol sterols
In the whole study population, serum cholesterol concentration
increased by age (r= 0.247, p < 0.01), and in the age group 6–10
years it was significantly higher than in the age group < 1 year
(Table 1). Of the non-cholesterol sterols, only lathosterol increased by
age (r= 0.460, p < 0.001), and it was higher in the oldest age group
compared with the three younger age groups (Table 1). Lathosterol was
also the only non-cholesterol sterol correlating with weight (r= 0.557,
p < 0.001).
Cholestenol and desmosterol were highest in the age group< 1
year, after which they were similar between the other age groups
(Table 1). Squalene was higher in the age group< 1 year compared
with the age groups 1–5 and 6–10 years.
Serum campesterol, stigmasterol, and avenasterol were lowest in
the age group<1 year (Table 1). Sitosterol, too, tended to be lowest in
the age group<1 year (p=0.068). The lowest plant sterol values were
observed in children less than six months of age, and campesterol and
avenasterol correlated with age in the age group<1 year (campesterol
(r= 0.599, p < 0.05, and avenasterol r= 0.787, p < 0.001). In the
three older age groups, the plant sterol ratios did not differ between the
groups. Cholestanol was similar between all age groups.
The ratios of cholestenol and lathosterol to cholestanol were highest
in the age group 11–15 years, shown for lathosterol/cholestanol in
Fig. 1. Lathosterol/desmosterol ratio was lowest in the age group< 1
year, but from the age of 6 years the ratio was no more changing.
Campesterol/cholestanol ratio was lowest in the age group<1 year,
after which it did not differ between the groups.
3.2. Interrelations of cholesterol precursors, plant sterols, and cholestanol
In the whole study population, lathosterol correlated with choles-
tenol, and the relationship was significant in all age groups (Table 2).
Squalene correlated with the other precursors only in the age group
6–10 years, shown for squalene-lathosterol in Table 2. Desmosterol
correlated with lathosterol only in the oldest age group (r= 0.740,
p < 0.001).
Campesterol, sitosterol, and avenasterol were interrelated in the
whole study population and in all age groups (Table 2) except for
sitosterol-avenasterol in the age group < 1 year (data not shown).
Cholestanol correlated with campesterol, sitosterol, and avenasterol in
the whole study population and in all other age groups except the age
Fig. 1. Ratios of serum lathosterol/cholestanol, lathosterol/desmosterol, and
campesterol/cholestanol (all μg/μg) in healthy children and adolescents at the
age of< 1 year (n=14), 1–5 years (n=37), 6–10 years (n=24), and 11–15
years (n= 21). Mean ± SE. Analysis of variance, p < 0.001, *from all other
age groups, †from the age group 11–15 years.
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group<1 year shown for campesterol-cholestanol in Table 2. Stig-
masterol correlated weakly with the other plant sterols and cholestanol
in the whole study population (r-values from 0.212 to 0.405,
p < 0.05), but not in the different age groups (data not shown).
3.3. Cholesterol homeostasis evaluated with non-cholesterol sterols
In the age group<1 year, cholesterol precursors did not associate
with plant sterols or cholestanol shown for lathosterol-campesterol and
lathosterol-cholestanol in Table 2. From the age group 1–5 years, la-
thosterol-cholestanol or lathosterol-campesterol were inversely inter-
related. Stigmasterol did not associate with any of the cholesterol
precursors.
4. Discussion
The new observations in the present study were as follows: serum
non-cholesterol sterols had different individual profiles by age in
childhood and adolescence from 0 to 15 years of age. These differences
could not be explained by age-related changes in the concentrations of
serum cholesterol and transporter lipoproteins, because the non-cho-
lesterol sterols were adjusted to cholesterol. There were no gender
differences in the non-cholesterol sterols in these age groups. Squalene,
cholestenol and desmosterol were higher in the age group<1 year
compared with the older age groups, whereas lathosterol was highest in
the age group 11–15 years. Plant sterols were low during the first year
of life and especially during the first six months of age. Cholestanol was
not related to age. Second, cholesterol homeostasis was not intact until
1 year of age. Third, from 1 to 10 years of age, cholesterol absorption
prevailed cholesterol synthesis.
Of the age-related differences in serum non-cholesterol sterols, we
first deal with the cholesterol precursors. After birth, the markedly
elevated serum desmosterol values decreased during the first year of
life, and after 1 year of age they were similar between the other age
groups. Since breast milk and infant formulas contain plenty of des-
mosterol, it is possible that the high serum desmosterol levels primarily
reflected their increased dietary intake rather than cholesterol synth-
esis. Breast milk contains desmosterol about 1 mg/100ml (0.03 mmol/
l) depending on the state of lactation, so that at the age of 5 months its
dietary intake can be up to 5–10mg/d [13,22–24]. The concept that
serum desmosterol is primarily diet-derived after birth is also supported
by the finding that in this age group desmosterol did not correlate with
any of the other cholesterol synthesis markers. On the other hand, the
elevated squalene and cholestenol levels< 1 year of age suggested that
cholesterol synthesis was activated in this age group.
Serum lathosterol level remained practically unchanged after birth
throughout the childhood until it increased in adolescence. This finding
resembles the results of an earlier study in 12-, 15-, and 18-year old
boys, in whom serum lathosterol increased gradually after 12 years of
age [14]. Accordingly, the present results suggest that during the first
year of life, and from the age of 11 years, cholesterol synthesis is ac-
tivated. However, during the first year of life, only the ‘early’ precursors
squalene and cholestenol are elevated in serum, whereas in the ado-
lescence serum lathosterol, the ‘late’ precursor is elevated. It remains
open why the cholesterol synthesis pathway is differently activated in
different ages. However, the lathosterol/desmosterol ratio showed that
from 6 years of age cholesterol synthesis was practically similarly di-
vided between the unsaturated Bloch and the saturated Kandutsch-
Russel pathways.
Plant sterols are not synthesized in the human body, and they are
diet-derived. Breast milk contains very little plant sterols, about 0.1
mg/100ml (0.003mmol/l) [13], whereas infant formulas contain
more, about 4 mg/100ml (0.1 mmol/l) [24]. Thus, the low campes-
terol/cholestanol ratio, which reflects the plant sterol intake [21],
suggested that the low serum plant sterol levels reflected primarily their
low intake. Accordingly, in this age group they cannot be considered as
cholesterol absorption markers.
Serum cholesterol precursors, plant sterols, and cholestanol are
biomarkers of whole-body cholesterol synthesis and absorption effi-
ciency validated in several adult populations [15–19]. To be certain
that they operated as expected also in this child population, we inter-
related the cholesterol precursors with each other in every age group as
well as the absorption markers. In addition, cholesterol homeostasis
was checked by relating the precursor sterols to the absorption markers
in every age group. It seems evident that cholestenol and lathosterol
were the most reliable biomarkers of cholesterol synthesis in every age
group. Interestingly, only in the age group 6–10 years, squalene cor-
related with all other precursors. Serum squalene was originally re-
ported as a marker of cholesterol synthesis especially in non-steady-
state situations [25], but later on, it was not associated with cholesterol
synthesis except in subjects with type 2 diabetes [19]. Its correlation
with the other precursors, especially in the age group 6–10 yrs, prob-
ably reflects a burst in cholesterol synthesis during these years.
Serum plant sterols except stigmasterol were tightly interrelated. In
the age group<1 year, they did not correlate with cholestanol, but
from the age of 1 year, plant sterols and cholestanol were interrelated.
Stigmasterol behaved differently, it associated only weakly with the
other plant sterols and cholestanol in the whole study population.
Stigmasterol was neither associated with any of the cholesterol pre-
cursors. Accordingly, even though being a plant sterol, stigmasterol
cannot be considered as a marker of cholesterol absorption.
Stigmasterol is the only plant sterol which in large concentrations, si-
mulating human phytosterolemia, is able to interfere with cholesterol
homeostasis. Thus, in adrenal cells of mice lacking ABCG5 and ABCG8
Table 2
Correlation coefficients between cholesterol precursors, plant sterols and cholestanol, and cholesterol homeostasis in different age groups and in the study popu-
lation.
Variables Age < 1 year n= 14 Age 1–5 years n= 37 Age 6–10 years n= 24 Age 11–15 years n= 21 Total n=96
Cholesterol precursors
Squalene-lathosterol 0.285 0.151 0.661c 0.158 0.174
Cholestenol-lathosterol 0.785c 0.563c 0.923c 0.930c 0.774c
Plant sterols and cholestanol
Campesterol-sitosterol 0.717b 0.909c 0.694c 0.899c 0.826c
Campesterol-avenasterol 0.823c 0.726c 0.775c 0.728c 0.831c
Cholestanol-campesterol 0.196 0.649c 0.746c 0.773c 0.677c
Cholesterol homeostasis
Lathosterol-campesterol −0.285 −0.286 −0.449a −0.779c −0.351c
Lathosterol-cholestanol −0.303 −0.417a −0.363 −0.740c −0.454c
μg/μg.
a p < 0.05.
b p < 0.01.
c p < 0.001.
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receptors, it reduced cholesterol synthesis by inhibiting SREBP-2 pro-
cessing, and it was able to activate the liver X receptor [26].
During the first year of life, there was no interaction between cho-
lesterol precursors and cholestanol, suggesting that cholesterol home-
ostasis was not yet developed. From the age of 1 year, cholesterol
homeostasis could be considered intact. According to Fig. 1, cholesterol
absorption prevailed cholesterol synthesis from the age of 1 to the age
of 10 years. Thus, the lathosterol/cholestanol ratios shown in Fig. 1
increased from the low levels in the 1–10 year old (0.35–0.45) to 0.66
in the age group 11–15 years. In fact, a similar lathosterol/cholestanol
ratio was observed earlier in 12-year old boys in The Cardiovascular
Risk in Young Finns Study, and the ratio still increased up to about 0.80
in the 18-year-old boys [14]. These previous results confirm our con-
clusion that in adolescence cholesterol synthesis prevails cholesterol
absorption. Whether this childhood profile of cholesterol metabolism
from 1 to 10 years of age with prevailing cholesterol absorption is
proatherogenic warrants further investigation. However, the prevailing
cholesterol absorption emphasizes to consider the importance of dietary
cardiovascular risk factors even from early childhood.
4.1. Limitations
The study population was a consecutive cohort of 0–15 year-old
day-surgery patients, who had a minor operation, removal of a benign
lesion, or endoscopy. The subjects had fasted overnight, and the blood
sample was drawn in the morning before the procedure. Otherwise the
subjects were considered healthy and they had followed their habitual
home diet so that it is conceivable that their cholesterol metabolism
was not interfered and they can be considered as a healthy study po-
pulation in steady-state. The assessment of the validity of serum non-
cholesterol sterols had to be based on the information obtained from
this study and based on whether cholesterol homeostasis was intact,
and whether the synthesis markers as well as the absorption markers
were interrelated. The absolute measurements of cholesterol metabo-
lism would have been impossible to perform in small children and in a
study population of this magnitude. Regarding the sample size, the
number of subjects in the different age groups exceeded the demands of
the power calculation. However, in the age group<1 years of age the
number of subjects was rather low even though excessing the limit of
power calculation, and somewhat gender-unbalanced, though statisti-
cally non-significant towards boys vs. girls. Moreover, a detailed dietary
information or the breastfeeding status was not recorded, so that data
should be interpreted with caution in this age group.
4.2. Conclusions
We have analysed cholesterol metabolism with serum non-choles-
terol sterol ratios to cholesterol in 0–15 year-old children and adoles-
cents without dyslipidemia. First, serum non-cholesterol sterols had
different individual profiles by age. Of the cholesterol synthesis markers
squalene and cholestenol were higher in the age group<1 year com-
pared with the older age groups, whereas lathosterol was highest in the
age group 11–15 years suggesting that cholesterol synthesis was acti-
vated in both age groups but with different biomarkers. Cholestanol
was not related to age. In the age group<1 year of age high serum
desmosterol and low plant sterols conceivably reflected their dietary
intake and cannot be used as biomarkers. Second, cholesterol home-
ostasis was not intact until from 1 years of age. Third, from 1 to 10
years of age, cholesterol absorption prevailed cholesterol synthesis.
This novel finding emphasizes the importance of dietary aspects related
to cardiovascular risk even from early childhood.
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